Bristol Days Sales Outstanding from 2010 to 2024

BMY Stock  USD 59.27  0.53  0.90%   
Bristol Myers Days Sales Outstanding yearly trend continues to be fairly stable with very little volatility. Days Sales Outstanding is likely to outpace its year average in 2024. During the period from 2010 to 2024, Bristol Myers Days Sales Outstanding regression line of annual values had r-squared of  0.69 and arithmetic mean of  92.76. View All Fundamentals
 
Days Sales Outstanding  
First Reported
2010-12-31
Previous Quarter
123.79149447
Current Value
129.98
Quarterly Volatility
21.86081443
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bristol Myers financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bristol Myers' main balance sheet or income statement drivers, such as Depreciation And Amortization of 10.3 B, Interest Expense of 1.2 B or Selling General Administrative of 3.6 B, as well as many indicators such as Price To Sales Ratio of 2.98, Dividend Yield of 0.0374 or PTB Ratio of 6.92. Bristol financial statements analysis is a perfect complement when working with Bristol Myers Valuation or Volatility modules.
  
Check out the analysis of Bristol Myers Correlation against competitors.

Latest Bristol Myers' Days Sales Outstanding Growth Pattern

Below is the plot of the Days Sales Outstanding of Bristol Myers Squibb over the last few years. It is Bristol Myers' Days Sales Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bristol Myers' overall financial position and show how it may be relating to other accounts over time.
Days Sales Outstanding10 Years Trend
Slightly volatile
   Days Sales Outstanding   
       Timeline  

Bristol Days Sales Outstanding Regression Statistics

Arithmetic Mean92.76
Geometric Mean90.31
Coefficient Of Variation23.57
Mean Deviation18.33
Median94.75
Standard Deviation21.86
Sample Variance477.90
Range66.119
R-Value0.83
Mean Square Error160.09
R-Squared0.69
Significance0.0001
Slope4.06
Total Sum of Squares6,691

Bristol Days Sales Outstanding History

2024 129.98
2023 123.79
2022 110.21
2021 98.49
2020 72.98
2019 107.29
2018 92.98

About Bristol Myers Financial Statements

Bristol Myers investors use historical fundamental indicators, such as Bristol Myers' Days Sales Outstanding, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bristol Myers. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Sales Outstanding 123.79  129.98 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bristol Stock Analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.